{"altmetric_id":13907152,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"total":{"posts_count":53},"news":{"unique_users_count":49,"unique_users":["biocentury","ktre","2_news","ticker_tech","ksla_news_12","wmbf_news","walb","newswest9","kait_tv","wmc_action_news_5","kusi_news","wlox","14_news","wrcb_tv","wtol","wtoc","news_channel","kuam","wflx_fox_29","wistv","kltv","klkn_tv_eyewitness_news","wboc_16","wtvm","hawaii_news_now","cbs8","wsfa","mississippi_news_now","cleveland_19","abc_7_news_kswo","kten","newson6","south_carolina_news_now","kfve_the_home_team","48_waff","fox_14_news","wave_3_news","wfmj","wand_17","wdam_tv","news_9","news_channel_6","wdrb","nbc12","khq","abc_6_news_wlne","nbc_right_now_kndu_25","kplc_7_news","biospace"],"posts_count":49},"twitter":{"unique_users_count":4,"unique_users":["Rob_Eureka","AnnemarieVtW","adi_singh14","BrJDermatol"],"posts_count":4}},"selected_quotes":["#EGALITY efficacy, safety, immunogenicity GP2015 #etanercept #biosimilar vs originator chronic plaque-type psoriasis","(3\/3) chronic plaque-type psoriasis","Enbrel v biosimilar. 531 PASI 50 responders. 3 treatment switches. Equivalent efficacy safety (BJD)"],"citation":{"abstract":"GP2015 is a proposed etanercept biosimilar.\nTo demonstrate equivalent efficacy, and comparable safety and immunogenicity of GP2015 and etanercept originator (ETN, Enbrel(\u00ae) ) in patients with moderate to severe chronic plaque-type psoriasis.\n531 eligible patients were randomised 1:1 to self-administer GP2015 or ETN twice-weekly subcutaneously. Patients with a 50% improvement in psoriasis area and severity index (PASI 50) at week 12 were re-randomised to continue the same treatment on a once-weekly dosing schedule or to undergo a sequence of 3 treatment switches between GP2015 and ETN until week 30. Thereafter, patients continued treatment with the product they had been assigned to last, up to week 52.\nThe difference in PASI 75 (75% improvement from baseline PASI score) response rates at week 12 between GP2015 and ETN (primary endpoint) was -2.3%. The 95% confidence interval (-9.85, 5.30) was well contained within the pre-specified margin range of (-18, 18). Incidence of treatment-emergent adverse events up to week 52 was comparable between continued GP2015 (59.8%) and ETN (57.3%); switching treatments revealed comparable safety profiles. Anti-drug antibodies, all non-neutralising, were limited to 5 patients on ETN during treatment period 1, and 1 patient in the switched ETN group, who had been treated with GP2015 for 12 weeks at time of the finding.\nThe EGALITY study demonstrated equivalent efficacy and comparable safety and immunogenicity of GP2015 and ETN. The study results provided the final clinical confirmation of biosimilarity and contributed to the totality-of-the-evidence proposing that GP2015 is an etanercept biosimilar. This article is protected by copyright. All rights reserved.","altmetric_jid":"4f6fa4e93cf058f610002442","authors":["Griffiths, C.E.M.","Tha\u00e7i, D.","Gerdes, S.","Arenberger, P.","Pulka, G.","Kingo, K.","Weglowska, J.","Hattebuhr, N.","Poetzl, J.","Woehling, H.","Wuerth, G.","Afonso, M.","C.E.M. Griffiths","D. Tha\u00e7i","S. Gerdes","P. Arenberger","G. Pulka","K. Kingo","J. Weglowska","N. Hattebuhr","J. Poetzl","H. Woehling","G. Wuerth","M. Afonso"],"doi":"10.1111\/bjd.15152","endpage":"938","first_seen_on":"2016-11-23T03:42:09+00:00","funders":["niehs"],"issns":["1365-2133","00070963"],"issue":"4","journal":"British Journal of Dermatology","last_mentioned_on":1501674598,"links":["http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.15152\/abstract","http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjd.15152\/abstract","http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjd.15152\/full","http:\/\/dx.doi.org\/10.1111\/bjd.15152"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjd.15152\/pdf","pmid":"27787890","pubdate":"2017-03-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"928","subjects":["dermatology"],"title":"The EGALITY study: A confirmatory, randomised, double-blind study comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, versus the originator product in patients with moderate to severe chronic plaque-type psoriasis.","type":"article","uri":"http:\/\/doi.wiley.com\/10.1111\/bjd.15152","volume":"176","mendeley_url":"http:\/\/www.mendeley.com\/research\/egality-study-confirmatory-randomized-doubleblind-study-comparing-efficacy-safety-immunogenicity-gp2"},"altmetric_score":{"score":389.6,"score_history":{"1y":389.6,"6m":380.5,"3m":378,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":389.6},"context_for_score":{"all":{"total_number_of_other_articles":8314034,"mean":7.0059620328577,"rank":13736,"this_scored_higher_than_pct":99,"this_scored_higher_than":8300402,"rank_type":"exact","sample_size":8314034,"percentile":99},"similar_age_3m":{"total_number_of_other_articles":277012,"mean":11.904890137936,"rank":1299,"this_scored_higher_than_pct":99,"this_scored_higher_than":275713,"rank_type":"exact","sample_size":277012,"percentile":99},"this_journal":{"total_number_of_other_articles":3674,"mean":5.5731685270896,"rank":5,"this_scored_higher_than_pct":99,"this_scored_higher_than":3669,"rank_type":"exact","sample_size":3674,"percentile":99},"similar_age_this_journal_3m":{"total_number_of_other_articles":100,"mean":7.7136363636364,"rank":1,"this_scored_higher_than_pct":99,"this_scored_higher_than":99,"rank_type":"exact","sample_size":100,"percentile":99}}},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Scientists":1,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":3,"Student  > Postgraduate":1,"Student  > Master":4,"Other":1,"Student  > Bachelor":2,"Lecturer":1,"Unspecified":1},"by_discipline":{"Medicine and Dentistry":6,"Social Sciences":1,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Pharmacology, Toxicology and Pharmaceutical Science":2,"Unspecified":1}}},"geo":{"twitter":{"AU":1,"NL":1,"IN":1,"GB":1},"mendeley":{"CA":1}}},"posts":{"news":[{"title":"Sandoz: Biosimilar matches Enbrel in switching study","url":"http:\/\/ct.moreover.com\/?a=28694849529&p=1pl&v=1&x=seTMelwV7Ln8Rm4VTTV0Ag","license":"public","citation_ids":[13907152],"posted_on":"2016-11-23T03:56:38+00:00","summary":"The Daily Extra, Clinical News Published on Tuesday, November 22, 2016 The Sandoz unit of Novartis AG (NYSE:NVS; SIX:NOVN) said there were \"no clinically meaningful differences\" between the safety or efficacy of its biosimilar Erelzietanercept-szzs\u2026","author":{"name":"BioCentury","url":"http:\/\/www.biocentury.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/410\/normal\/Screen_Shot_2015-12-10_at_14.50.19.png?1449759038"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396060821&p=1pl&v=1&x=QLQRG6Gdizy0gF5HcPwMJg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:41:34+00:00","summary":"Information contained on this page is provided by an independent third-party content provider.","author":{"name":"KTRE","url":"http:\/\/www.ktre.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/705\/normal\/Screen_Shot_2016-01-26_at_15.04.21.png?1453820750"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396012760&p=1pl&v=1&x=KD4xqBFBAJtbtfIX6FRuzQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"Information contained on this page is provided by an independent third-party content provider.","author":{"name":"2 News","url":"http:\/\/www.ktvn.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/654\/normal\/Screen_Shot_2016-01-26_at_12.05.19.png?1453809947"}},{"title":"Sandoz Erelzi\u00e2\u201e\u00a2 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395935303&p=1pl&v=1&x=PAiynOyX0DHA4LCQYHt97A","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:26:45+00:00","summary":"Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00c3\u201a\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.","author":{"name":"Ticker Tech","url":"http:\/\/www.tickertech.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/724\/normal\/Screen_Shot_2016-01-26_at_15.37.40.png?1453822700"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395946626&p=1pl&v=1&x=DEfJnVQ5vUHLKMzjiiQ3jw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:15+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KSLA News 12","url":"http:\/\/www.ksla.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/709\/normal\/Screen_Shot_2016-01-26_at_15.10.50.png?1453821079"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395951134&p=1pl&v=1&x=O7Y_5PPCvNn4E-4pIfa2QQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:45+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WMBF News","url":"http:\/\/www.wmbfnews.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/710\/normal\/Screen_Shot_2016-01-26_at_15.11.39.png?1453821128"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395949421&p=1pl&v=1&x=DSlWG--7gBxQT87d1pwb2Q","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WALB","url":"http:\/\/www.walb.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/647\/normal\/Screen_Shot_2016-01-26_at_11.47.02.png?1453808851"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395951252&p=1pl&v=1&x=AOYb8tytQk8NhwP5Q2QIJg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:46+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"NewsWest9","url":"http:\/\/www.newswest9.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/703\/normal\/Screen_Shot_2016-01-26_at_14.52.45.png?1453820009"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395954844&p=1pl&v=1&x=J923HU1chQGh9i8eIFQYCA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KAIT-TV","url":"http:\/\/www.kait8.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/672\/normal\/Screen_Shot_2016-01-26_at_14.02.53.png?1453817085"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395961478&p=1pl&v=1&x=WjS6WYgdDCXaZaCu97eTfg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WMC Action News 5","url":"http:\/\/www.wmcactionnews5.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/727\/normal\/Screen_Shot_2016-01-26_at_15.42.23.png?1453822987"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395961942&p=1pl&v=1&x=J-qhRW2NgKuq9oXR89KxJA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:30:08+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KUSI News","url":"http:\/\/www.kusi.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/663\/normal\/Screen_Shot_2016-01-26_at_13.26.05.png?1453815145"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395962308&p=1pl&v=1&x=54cyFeS4RiOUpzhlzjrLpQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:30:11+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WLOX","url":"http:\/\/www.wlox.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/657\/normal\/Screen_Shot_2016-01-26_at_12.08.48.png?1453810156"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395965001&p=1pl&v=1&x=vxkcwtYH3vwfI8BACpNKUw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:30:32+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"14 News","url":"http:\/\/www.14news.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/696\/normal\/Screen_Shot_2016-01-26_at_14.43.50.png?1453819462"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395966574&p=1pl&v=1&x=Clk9RYVVhfL9q2zF-Nq5XA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WRCB- TV","url":"http:\/\/www.wrcbtv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/690\/normal\/Screen_Shot_2016-01-26_at_14.32.42.png?1453818828"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395967201&p=1pl&v=1&x=H2deqRlHsauYuQWsAO3rNw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:30:44+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WTOL","url":"http:\/\/www.wtol.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/662\/normal\/Screen_Shot_2016-01-26_at_12.19.14.png?1453810785"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395968856&p=1pl&v=1&x=9MLQ_t5aJ2Y__64kGxEh3Q","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:30:53+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WTOC","url":"http:\/\/www.wtoc.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/688\/normal\/Screen_Shot_2016-01-26_at_14.30.16.png?1453818642"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395970699&p=1pl&v=1&x=WUfGRJgjlTKcDSp-0WjXIA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"News Channel","url":"http:\/\/www.kxxv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/645\/normal\/Screen_Shot_2016-01-26_at_11.42.27.png?1453808595"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395970939&p=1pl&v=1&x=QOL2MK21I_YCb8g9uN3tQQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:31:07+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Kuam","url":"http:\/\/www.kuam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/667\/normal\/Screen_Shot_2016-01-26_at_13.48.34.png?1453816300"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395971941&p=1pl&v=1&x=moc_DLWAUsp9B0fCD0JRxg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WFLX Fox 29","url":"http:\/\/www.wflx.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/656\/normal\/Screen_Shot_2016-01-26_at_12.07.36.png?1453810094"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395972079&p=1pl&v=1&x=0tets6rkv54IgbmPMy-BhQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WISTV","url":"http:\/\/www.wistv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/689\/normal\/Screen_Shot_2016-01-26_at_14.30.56.png?1453818748"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395976347&p=1pl&v=1&x=vzi5Xsha1cph_MHvfrNASA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:31:44+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KLTV","url":"http:\/\/www.kltv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/704\/normal\/Screen_Shot_2016-01-26_at_14.54.15.png?1453820113"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395977348&p=1pl&v=1&x=GfcvegewQ_nG-yd7gmmkhg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KLKN-TV Eyewitness News","url":"http:\/\/www.klkntv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/655\/normal\/Screen_Shot_2016-01-26_at_12.06.08.png?1453810028"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395979233&p=1pl&v=1&x=9UwgHBdtCInRoBptLD9DIw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:32:06+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WBOC 16","url":"http:\/\/www.wboc.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/717\/normal\/Screen_Shot_2016-01-26_at_15.23.21.png?1453821908"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395981377&p=1pl&v=1&x=jGKsQK23rcmoDl3XfleHPg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:32:20+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WTVM","url":"http:\/\/www.wtvm.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/646\/normal\/Screen_Shot_2016-02-02_at_14.58.13.png?1454425111"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395982182&p=1pl&v=1&x=QUlyWaScy7nIftBLv3Wfnw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Hawaii News Now","url":"http:\/\/www.hawaiinewsnow.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/661\/normal\/Screen_Shot_2016-01-26_at_12.16.42.png?1453810633"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395987303&p=1pl&v=1&x=Yp80Y3zUdF8xPPK1wFTHBg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:33:03+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"CBS8","url":"http:\/\/www.cbs8.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/681\/normal\/Screen_Shot_2016-01-26_at_14.17.19.png?1453817863"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395993471&p=1pl&v=1&x=vnS1W23OjPX6wf4UE9bc9w","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WSFA ","url":"http:\/\/www.wsfa.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/644\/normal\/Screen_Shot_2016-01-26_at_11.40.39.png?1453808470"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31395998398&p=1pl&v=1&x=_04j-7ONMR1s9VpN8mjymg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:34:27+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Mississippi News Now ","url":"http:\/\/www.msnewsnow.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/649\/normal\/Screen_Shot_2016-01-26_at_11.57.00.png?1453809440"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396000686&p=1pl&v=1&x=6k5wFnTfFUdJ-b6yaF1F0Q","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:34:43+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Cleveland 19","url":"http:\/\/www.cleveland19.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/683\/normal\/Screen_Shot_2016-01-26_at_14.20.50.png?1453818081"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396003999&p=1pl&v=1&x=aVGtQ5F5mxoQc1fOv6ALQw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:35:07+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"ABC 7 News KSWO","url":"http:\/\/www.kswo.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/708\/normal\/Screen_Shot_2016-01-26_at_15.08.58.png?1453821021"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396007761&p=1pl&v=1&x=5Y-Mq4Kf8QRNQDAaAWL1oA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KTEN","url":"http:\/\/www.kten.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/643\/normal\/Screen_Shot_2016-01-26_at_11.36.58.png?1453808251"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396009047&p=1pl&v=1&x=yzg6HjL9wmeKwdWfH8tQ2Q","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:35:39+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"NewsOn6","url":"http:\/\/www.newson6.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/677\/normal\/Screen_Shot_2016-01-26_at_14.12.15.png?1453817572"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396019937&p=1pl&v=1&x=YWc444-YwGMq86yWLgj4XA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:36:52+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"South Carolina News Now","url":"http:\/\/www.live5news.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/730\/normal\/Screen_Shot_2016-01-26_at_15.47.02.png?1453823263"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396033851&p=1pl&v=1&x=FWuPO9zaLPR6CvJNl8HBXg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KFVE The Home Team","url":"http:\/\/www.k5thehometeam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/734\/normal\/Screen_Shot_2016-01-26_at_15.53.15.png?1453823633"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396035485&p=1pl&v=1&x=Et8NZdye1z67JyAdnkNnzw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"48 WAFF","url":"http:\/\/www.waff.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/699\/normal\/Screen_Shot_2016-01-26_at_14.47.41.png?1453819680"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396037242&p=1pl&v=1&x=CatsQTnL3A601wda1nWaxw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:39:24+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Fox 14 News","url":"http:\/\/www.fox14tv.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/651\/normal\/Screen_Shot_2016-01-26_at_12.00.07.png?1453809650"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396050574&p=1pl&v=1&x=-afzFdmsxAN33wYS2HT8WQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:40:39+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"Wave 3 News","url":"http:\/\/www.wave3.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/697\/normal\/Screen_Shot_2016-01-26_at_14.44.55.png?1453819521"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396052812&p=1pl&v=1&x=6mpqAbadgeSZxp0T1M34HA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WFMJ","url":"http:\/\/www.wfmj.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/701\/normal\/Screen_Shot_2016-01-26_at_14.49.34.png?1453819812"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396059567&p=1pl&v=1&x=cO3nPSVLzjF8aUp-wE2KLw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WAND 17","url":"http:\/\/www.wandtv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/694\/normal\/Screen_Shot_2016-01-26_at_14.41.02.png?1453819294"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396070477&p=1pl&v=1&x=gZU1Nf1D4qAdSxbgR3itjw","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:42:42+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WDAM - TV","url":"http:\/\/www.wdam.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/682\/normal\/Screen_Shot_2016-01-26_at_14.19.46.png?1453818016"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396071872&p=1pl&v=1&x=dWjyXMB8yE7Dm2nzdsmTUg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:42:52+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"News 9","url":"http:\/\/www.news9.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/691\/normal\/Screen_Shot_2016-01-26_at_14.34.55.png?1453818924"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396093079&p=1pl&v=1&x=5CHYzzTOBHfRZ2-mU2i8RA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:44:59+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"News Channel 6","url":"http:\/\/www.newschannel6now.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/652\/normal\/Screen_Shot_2016-01-26_at_12.01.23.png?1453809711"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396111893&p=1pl&v=1&x=oD_qUpsw9E_Wiz_l0ol1XA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:47:09+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"WDRB","url":"http:\/\/www.wdrb.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/693\/normal\/Screen_Shot_2016-01-26_at_14.37.05.png?1453819066"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396119290&p=1pl&v=1&x=lm03NX6ywS-VsRPWQKJNxA","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:48:10+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"NBC12","url":"http:\/\/www.nbc12.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/702\/normal\/Screen_Shot_2016-01-26_at_14.51.21.png?1453819926"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396119755&p=1pl&v=1&x=HlPyf8pk8AGJESGLS2FZEQ","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:48:14+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KHQ","url":"http:\/\/www.khq.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/658\/normal\/Screen_Shot_2016-01-26_at_12.10.14.png?1453810239"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396120947&p=1pl&v=1&x=R92QWVHdGhIhXmKLaBtNTg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:29:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"ABC 6 News WLNE","url":"http:\/\/www.abc6.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/712\/normal\/Screen_Shot_2016-01-26_at_15.16.08.png?1453821391"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396133470&p=1pl&v=1&x=8PXUST5tM5NiGO211iomCg","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:49:58+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"NBC Right Now KNDU 25","url":"http:\/\/www.nbcrightnow.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/735\/normal\/Screen_Shot_2016-01-26_at_15.54.16.png?1453823699"}},{"title":"Sandoz Erelzi\u2122 (etanercept) receives positive reimbursement recommendation from Common Drug Review for treatment of multiple inflammatory diseases","url":"http:\/\/ct.moreover.com\/?a=31396145739&p=1pl&v=1&x=e4vdE4GKpH6urnh5nCGN5A","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T11:28:00+00:00","summary":"SOURCE Sandoz Canada Positive recommendation is based on the condition that ErelziTM be reimbursed in a manner similar to Enbrel\u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.Positi\u2026","author":{"name":"KPLC 7 News","url":"http:\/\/www.kplctv.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/641\/normal\/Screen_Shot_2016-01-26_at_11.30.17.png?1453807834"}},{"title":"Sandoz Canada Release: Sandoz Erelzi (Etanercept) Receives Positive Reimbursement Recommendation From Common Drug Review For Treatment Of Multiple Inflammatory Diseases","url":"http:\/\/ct.moreover.com\/?a=31398972848&p=1pl&v=1&x=3Ww_AvM2BYu566aJ0r-X_A","license":"public","citation_ids":[13907152],"posted_on":"2017-08-02T00:00:00+00:00","summary":"Positive recommendation is based on the condition that Erelzi TM be reimbursed in a manner similar to Enbrel \u00ae for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis, and Polyarticular Juvenile Idiopathic Arthritis.","author":{"name":"Biospace","url":"http:\/\/www.biospace.com","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/375\/normal\/biospace.png?1437140433"}}],"twitter":[{"url":"http:\/\/twitter.com\/Rob_Eureka\/statuses\/803765566205030401","license":"gnip","citation_ids":[13907152],"posted_on":"2016-11-30T01:00:18+00:00","author":{"name":"Robert Huggan","url":"http:\/\/au.linkedin.com\/pub\/robert-huggan\/24\/9b9\/793","image":"https:\/\/pbs.twimg.com\/profile_images\/3629762428\/0cf9e354f1af479e7e806ebca461b051_normal.jpeg","description":"Pharma Sales and Marketing contractor specializing in Business Development and data analytics.:  http:\/\/www.EurekaPharma.com.au","id_on_source":"Rob_Eureka","tweeter_id":"1335800671","geo":{"lt":-33.86785,"ln":151.20732,"country":"AU"},"followers":1343},"tweet_id":"803765566205030401"},{"url":"http:\/\/twitter.com\/AnnemarieVtW\/statuses\/806416749314867200","license":"gnip","citation_ids":[13907152],"posted_on":"2016-12-07T08:35:10+00:00","author":{"name":"A. Vroom - Ten Wolde","url":"http:\/\/nl.linkedin.com\/in\/annemarievroomtenwolde","image":"https:\/\/pbs.twimg.com\/profile_images\/1118347634\/Annemarie-photo_normal.png","description":"PhD Organic Chemistry; Science Writer #Biotech\/#Pharma #biologics #biosimilars #antibody #mAbs #ADCs #bispecifics #biobetters #health #chemistry","id_on_source":"AnnemarieVtW","tweeter_id":"185567498","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":2239},"tweet_id":"806416749314867200"},{"url":"http:\/\/twitter.com\/adi_singh14\/statuses\/806526798683111424","license":"gnip","rt":["AnnemarieVtW"],"citation_ids":[13907152],"posted_on":"2016-12-07T15:52:28+00:00","author":{"name":"Adi Singh","url":"https:\/\/www.linkedin.com\/in\/adisinghh","image":"https:\/\/pbs.twimg.com\/profile_images\/885718281813872640\/-Y4E-5vT_normal.jpg","description":"#Pharma #Healthcare #management consulting professional, #music-lover #photographer, #Interest: #Biosimilars & #MnA. Tweets\/post r personal!","id_on_source":"adi_singh14","tweeter_id":"1481745314","geo":{"lt":28.63576,"ln":77.22445,"country":"IN"},"followers":75},"tweet_id":"806526798683111424"},{"url":"http:\/\/twitter.com\/BrJDermatol\/statuses\/859149183953055746","license":"gnip","citation_ids":[13907152],"posted_on":"2017-05-01T20:55:02+00:00","author":{"name":"BJD","url":"http:\/\/www.brjdermatol.org","image":"https:\/\/pbs.twimg.com\/profile_images\/3662912925\/50a21aafa84f2fca31b006e06e0da1b1_normal.jpeg","description":"The official twitter account of The British Journal of Dermatology","id_on_source":"BrJDermatol","tweeter_id":"1430713760","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":2305},"tweet_id":"859149183953055746"}]}}